GSK Looks To Unload Lucozade, Ribena Energy Drink Brands

Law360, New York (April 24, 2013, 1:12 PM EDT) -- U.K. pharmaceutical giant GlaxoSmithKline PLC has decided to unload the popular energy drink brands Lucozade and Ribena as it looks to focus on emerging markets, deals that could fetch more than £1 billion ($1.53 billion) combined, according to an earnings release by GSK on Wednesday.

In a release announcing its 2013 first-quarter financials, GSK said it completed a strategic review of Lucozade and Ribena earlier this month.

We "concluded that the tremendous growth potential of these iconic brands, particularly outside the ‘core’ Western markets, could be...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.